The DOI matches its Crossref record; 168 of the 168 references it cites were found in a registry or an index; 86 of the 173 sources its claims cite were checked for support.
Adolescent nicotine exposure and persistent neurocircuitry changes: unveiling lifelong psychiatric risks
Open accessAbstract
Nicotine exposure during adolescence has emerged as a significant risk factor for later psychiatric disease. Notably, adolescence is a critical period for the maturation of acetylcholine and dopamine systems, neuromodulators which tightly regulate cognitive, motivational and emotional behaviors known to contribute to psychiatric vulnerability. This review explores whether long-lasting modifications in these neuromodulatory systems following adolescent nicotine exposure underlie the increased vulnerability to mental health disorders. We discuss evidence that nicotine in adolescence leads to enduring molecular, cellular alterations by perturbing the normal trajectory of cholinergic and dopamine systems, and link these changes with potential adverse behavioral outcomes in adulthood. We propose that persistent alterations in acetylcholine and dopamine signaling caused by adolescent nicotine exposure may contribute to the heightened risk for psychiatric disorders including substance abuse, anxio-depressive disorders, and schizophrenia for which deficits in a large spectrum of motivational domains are highly prevalent. The interaction between nicotine and these developing neurotransmitter systems during adolescence raises important questions about the mechanisms driving these changes. Finally, we discuss limitations in the current research and subsequently identify open questions in the field which will help drive forward research on the psychiatric consequences of adolescent nicotine use. Understanding these maladaptations could pave the way for targeted therapeutic strategies to mitigate the adverse effects of adolescent nicotine exposure on brain development and subsequent psychiatric outcomes.
Overview
CoChat Summary
## TL;DR
This is a review of animal and translational evidence arguing that nicotine exposure during adolescence can cause lasting changes in cholinergic and dopaminergic circuitry. The authors link these persistent neuroadaptations to increased adult risk for addiction and mood- or psychosis-related outcomes, while emphasizing that the literature is limited and heterogeneous.
## Key findings
- The review states that nicotine exposure during adolescence is associated with increased risk of later psychiatric disease, including substance abuse, anxio-depressive disorders, and schizophrenia.
- In animal models, adolescent nicotine exposure increased later nicotine reward sensitivity and reduced aversion: adult mice exposed in early adolescence consumed more nicotine, were less affected by its negative effects, and showed greater sensitivity to its rewarding properties.
- The paper reports sex- and age-specific behavioral effects: mid-adolescent nicotine exposure (PND 35–44) induced anxiety-like behavior and persistent depressive-like behavior in adult rats, with these effects reported as specific to male rats.
- The authors describe persistent neurobiological changes after adolescent nicotine exposure, including increased α4β2 nAChR binding persisting into adulthood in the PFC and midbrain after 2 weeks of mid-adolescent exposure (PND 30–47), as well as altered DA circuit function such as increased electrically evoked DA release in the adult PFC after mid-adolescent exposure (PND 34–43).
## Methods
- Narrative review of preclinical and translational literature on adolescent nicotine exposure, with emphasis on long-term effects on cholinergic and dopaminergic systems.
- The review synthesizes rodent studies spanning defined adolescent windows, especially early, middle, and late adolescence in rodents (roughly PND 21–60), and compares outcomes by exposure timing, dose/route, and sex.
- Main analysis is qualitative: the authors integrate findings across behavioral assays, receptor binding/expression studies, electrophysiology, and circuit-level interventions such as chemogenetics.
## Limitations
- The paper states that adolescent age definitions are not standardized, and the same nicotine exposure at different adolescent ages can produce different outcomes.
- It notes that not all studies include an adult control group, which makes it impossible to conclude that observed effects are specific to adolescent exposure rather than exposure in general.
- The paper says nicotine dose and route vary widely across studies, complicating comparison and replication of human adolescent use patterns.
- It also highlights sex-difference handling as a limitation: some studies include both sexes, while others use only one sex or do not adequately account for sex differences.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


![Fig. 3 Nicotine exposure in adolescence leads to immature response to nicotine in adulthood. Adolescent mice show an increased rewarding effect of nicotine, paired with a blunted anxiogenic effect of the drug in comparison to adults. These differences result from an imbalance in dopamine neuron response to nicotine at the circuit level [150]. Adult mice that were exposed to nicotine in adolescence show similar behavioral and electrophysiological responses to nicotine, suggesting that adolescent exposure arrests the development of dopaminergic circuitry.](https://figures.cochat.ai/paper-figures/8d3797e8371944eda3f3e9d69ab5a1dc/adolescent-nicotine-exposure-and-persistent-neurocircuitry-changes-unveiling-figure-3.jpg)

Verification
Claims the paper makes
47 Valid · 5 Not valid · 32 Not checked · 28 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Nicotine use in adolescence has been shown to predict the later appearance of depression symptoms [6–10].”
§ Adolescent nicotine exposure and persistent neurocircuitry changes: unveiling lifelong psychiatric risks > Introduction
What the sources say
- Not checked — no full text of the sourcecites [6] Choi WS, Patten CA, Gillin JC, Kaplan RM, Pierce JP. Cigarette smoking predicts development of depressive symptoms among U.S. adolescents. Ann Behav Med. 1997;19:42–50. source
- Not checked — no full text of the sourcecites [7] Wu LT, Anthony JC. Tobacco smoking and depressed mood in late childhood and early adolescence. Am J Public Health. 1999;89:1837–40. source
- Not checked — no full text of the sourcecites [8] Goodman E, Capitman J. Depressive symptoms and cigarette smoking among teens. Pediatrics. 2000;106:748–55. source
- Supportedcites [9] Ranjit A, Buchwald J, Latvala A, Heikkilä K, Tuulio-Henriksson A, Rose RJ, et al. Predictive association of smoking with depressive symptoms: a longitudinal study of adolescent twins. Prev Sci. 2019;20:1021–30. source
The Discussion reports that adolescent smokers had higher depressive-symptom scores later than never-smokers and concludes that early-adolescent cigarette smoking predicts more symptoms later in adolescence. The paper cautions that this association is likely confounded and does not establish causation; the citing sentence makes a predictive, not causal, claim. (LLM, conf=0.89)
- Partly supportedcites [10] Baiden P, Szlyk HS, Cavazos-Rehg P, Onyeaka HK, Peoples JE, Kasson E. Use of electronic vaping products and mental health among adolescent high school students in the United States: the moderating effect of sex. J Psychiatr Res. 2022;147:24–33. sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) reports that cigarette smoking at age 14 significantly predicted depressive symptoms at age 17. That supports a later association for adolescent cigarette smoking, but it does not establish the first appearance of symptoms or the same prediction for nicotine use generally. (LLM, conf=0.82)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“striking, age-dependent differences can be reported in the enduring effects of the same experience on neural circuitry depending on the adolescent period in which this experience occurred [48–51].”
§ Adolescent nicotine exposure and persistent neurocircuitry changes: unveiling lifelong psychiatric risks > Adolescent development of neuromodulatory systems in translational models While this period is most often thought of in the context of human teenagers, it is increasingly recognized to be evolutionarily conserved, with animal species also showing distinct markers of an adolescent state [35–40]. Defining the boundaries of adolescence has proved challenging, as there are not clear hallmarks to signal the onset or completion of adolescent development. While puberty and adolescence occur during the same time period, they are not necessarily synonymous: puberty represents the process of attaining sexual maturity, while adolescence is a more diffuse period marked by significant neurobiological, behavioral and social changes. Thus, the age boundaries of the adolescent period are difficult to precisely define. Modern definitions of the human adolescent period range between 10 and 24 years of age [35, 41], an age range where children show dramatic behavioral changes and the human brain undergoes significant restructuring [22, 23, 42, 43]. While there is no clear consensus on the age range of adolescence in animal models, adolescence in rodents is increasingly defined more in line with this larger age window in humans, by counting the period from weaning (~PND 21) where mice and rats gain begin to interact independently with their environments for the first time, leading to a wealth of experiences with the potential to enduringly impact adult behavioral phenotypes and their underlying neuronal circuits. Rodents show behavioral and neurobiological markers of development until neurobiological maturity is reached around two months of age (~PND 60) [36, 38, 39, 44–47]. The adolescent period can be further sub-divided into early (~PND 21–34), middle (~PND 35–45), and late (~PND 45–60) periods [39, 46], which coincide roughly with pre- peri- and post-pubertal periods (Fig. 1). It is important to define these time windows, as striking, age-dependent differences can be reported in the enduring effects of the same experience on neural circuitry depending on the adolescent period in which this experience occurred [48–51]. Thus, we take great care in this review to be as specific as possible about the age at which nicotine exposure occurred during adolescence. Studies in rodent models have begun to elucidate the complex development of neuromodulatory neurotransmitter circuits in adolescence, including those most likely to be directly affected by adolescent nicotine use. Nicotine usurps the action of endogenous acetylcholine (ACh) by signaling through nicotinic acetylcholine receptors (nAChRs), a diverse family of pentameric ligand-gated cation channels [52]. While nAChRs are present throughout the brain at all developmental stages, maturational patterns in their expression and function have been identified [53, 54]. Notably, expression of the most abundant and high-affinity α4β2-containing nAChRs across the brain peaks in adolescence before diminishing to adult levels [55–58], and this peak has been suggested to underlie elevated nicotine self-administration in adolescent animals [59]. This increased nAChR expression was notably observed within the striatum and the midbrain [59]. Studies with greater regional specificity have shown that expression of α4- containing nAChRs in the VTA peaks late in adolescence, and is positively correlated with nicotine intake in an oral self-administration task (Fig. 2A) [60]. Rubidium efflux assays, an index of potassium channel activity, indicate higher nAChR receptor functionality in adolescents than in adults in the cortex, striatum, hippocampus, and thalamus (Fig. 2A) [61, 62]. In parallel to the developmental plasticity of cholinergic receptors, activity of choline acetyltransferase (ChAT), a requisite enzyme for ACh synthesis that also reflects the density of cholinergic innervation, increases from adolescence to adulthood in both the cortex and midbrain (Fig. 2A) [63]. At the cellular level, electrophysiological response to nicotine in cholinergic cells from the laterodorsal tegmentum (LDT), a small brain region located in the brainstem that constitutes the primary source of ACh to the ventral tegmental area (VTA) [64, 65], changes across development, with a larger excitatory response in cells from juvenile mice (PND 7–15) than in late juvenile/early adolescent mice (PND 15–34). This change in nicotine responsivity in LDT neurons is thought to represent a developmental reorganization of the nAChR subunits present on these cells [66, 67]. ACh provides a complex regulation of reward and motivation behaviors through its actions on dopamine (DA) circuitry [68–72]. The release of ACh from LDT projections directly modulates activity of VTA DA neurons, finely tuning their firing rate and burst properties [73, 74]. DA signaling in the striatum is also modulated at the terminal level by ACh release from local striatal cholinergic interneurons [75], but also from an external direct cholinergic input from the LDT [76]. Hence, ACh signaling through presynaptic and somato-dendritic nAChRs tightly regulates DA circuit activity, suggesting that it is another neuromodulatory system profoundly affected by developmental exposure to nicotine. Dopamine circuits undergo a robust period of maturation in adolescence, including changes to innervation patterns, dopamine synthesis and release, basal dopamine neuron firing rates, and dopamine receptor expression in terminal areas, with particularly pronounced changes in mesocortical and mesolimbic circuits (Fig. 2B) [39, 77–82]. Of note, the segregation of mesocorticolimbic dopamine pathways continues in adolescence, with a subset of dopamine axons passing through limbic regions before growing to the PFC [83]. The targeting processes of these axons can be disrupted by experience with stimulant drugs of abuse in adolescence, such as amphetamine [49, 51], or by stress [84], resulting in enduring cognitive deficits. The development of dopaminergic and cholinergic systems may also be inter-related. Adolescent rodents show greater DA release in the NAc in response to acute nicotine when compared to adult counterparts, despite similar baseline measures [85, 86]. Electrophysiological response of VTA DA neurons to acute nicotine also changes across development, with an increased sensitivity in early adolescent animals [87]. Molecular evidence links these changes to maturation in VTA nAChR expression, as mRNA transcripts of α5 α6 and α7 nAChR receptor subunits in the VTA peak early in adolescence (Fig. 2A), in tandem to nicotine-stimulated DA release in the ventral striatum [88]. Together, these results suggest that nicotine in adolescence produces different immediate and long-term outcomes through its actions on these developing neurotransmitter systems.
What the sources say
- Not checked — no full text of the sourcecites [48] Yetnikoff L, Pokinko M, Arvanitogiannis A, Flores C. Adolescence: a time of transition for the phenotype of dcc heterozygous mice. Psychopharmacology. 2014;231:1705–14. source
- Supportedcites [49] Reynolds LM, Yetnikoff L, Pokinko M, Wodzinski M, Epelbaum JG, Lambert LC, et al. Early adolescence is a critical period for the maturation of inhibitory behavior. Cereb Cortex. 2019;29:3676–86. source
The Abstract reports that the same amphetamine regimen caused lasting changes in prefrontal dopamine connectivity in male mice when given during early adolescence, but not at later ages. This supports the cited sentence’s point that the enduring effects of an experience on neural circuitry can depend on when in adolescence it occurs. (LLM, conf=0.92)
- Not checked — no full text of the sourcecites [50] Yetnikoff L, Almey A, Arvanitogiannis A, Flores C. Abolition of the behavioral phenotype of adult netrin-1 receptor deficient mice by exposure to amphetamine during the juvenile period. Psychopharmacology. 2011;217:505–14. source
- Supportedcites [51] Reynolds LM, Hernandez G, MacGowan D, Popescu C, Nouel D, Cuesta S, et al. Amphetamine disrupts dopamine axon growth in adolescence by a sex-specific mechanism in mice. Nat Commun. 2023;14:4035. source
The Discussion (page unavailable) describes rerouting of dopamine axons after amphetamine exposure as a sex- and age-dependent consequence of an adolescent experience. The Results report altered prefrontal dopamine innervation in adult male mice exposed in early adolescence, supporting this as an example of an enduring, age-dependent effect on circuitry. (LLM, conf=0.91)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These neurobiological changes underlie the profound maturation in motivational and cognitive domains across adolescence [30–34]”
§ Adolescent nicotine exposure and persistent neurocircuitry changes: unveiling lifelong psychiatric risks > Introduction
What the sources say
- Supportedcites [30] Wahlstrom D, White T, Luciana M. Neurobehavioral evidence for changes in dopamine system activity during adolescence. Neurosci Biobehav Rev. 2010;34:631–48. source
The Introduction links adolescent behavioral changes to brain maturation, identifying prefrontal systems involved in regulation and limbic–striatal systems involved in motivation. The section 'An Overview of Behavioral and Brain Development in Adolescence' also describes continued maturation of cognitive and motivated-decision-making abilities. Page numbers were not supplied for these passages. (LLM, conf=0.87)
- Partly supportedcites [31] Luciana M, Wahlstrom D, Porter JN, Collins PF. Dopaminergic modulation of incentive motivation in adolescence: age-related changes in signaling, individual differences, and implications for the development of self-regulation. Dev Psychol. 2012;48:844–61. sourceExperimental — accuracy not yet measured
The Neurobiological Foundation and Concluding Comments link adolescent neural and dopamine changes to the development of incentive motivation. The Concluding Comments also describe a developing cognitive-behavioral control system, but treat dopamine’s role as a proposed mechanism and do not establish that the described changes underlie broad cognitive maturation. (LLM, conf=0.83)
- Partly supportedcites [32] Tervo-Clemmens B, Calabro FJ, Parr AC, Fedor J, Foran W, Luna B. A canonical trajectory of executive function maturation from adolescence to adulthood. Nat Commun. 2023;14:6922. sourceExperimental — accuracy not yet measured
The Introduction describes adolescence as a period of cognitive and affective maturation, and the Discussion reports continued development of goal-directed cognition into late adolescence. The cited paper does not establish that neurobiological changes underlie this maturation, nor does it directly document maturation in the motivational domain. (LLM, conf=0.84)
- Supportedcites [33] Somerville LH, Hare T, Casey BJ. Frontostriatal maturation predicts cognitive control failure to appetitive cues in adolescents. J Cogn Neurosci. 2011;23:2123–34. source
The introductory passage (page not provided) describes changing interactions between brain circuitry for motivation and cognitive control across development. The Discussion conclusion likewise links adolescent motivational drives and developing regulatory capacity to these neural systems, supporting the broad claim. (LLM, conf=0.87)
- Partly supportedcites [34] Liston C, Watts R, Tottenham N, Davidson MC, Niogi S, Ulug AM, et al. Frontostriatal microstructure modulates efficient recruitment of cognitive control. Cereb Cortex. 2006;16:553–60. sourceExperimental — accuracy not yet measured
The Introduction (page not provided) describes frontostriatal maturation through adolescence alongside developing cognitive control, and the Discussion links frontostriatal connectivity to that capacity. The paper does not address maturation in the motivational domain; its reported comparison is primarily between children and adults, rather than a demonstration of change across adolescence. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“expression of the most abundant and high-affinity α4β2-containing nAChRs across the brain peaks in adolescence before diminishing to adult levels [55–58]”
§ Adolescent nicotine exposure and persistent neurocircuitry changes: unveiling lifelong psychiatric risks > Adolescent development of neuromodulatory systems in translational models While this period is most often thought of in the context of human teenagers, it is increasingly recognized to be evolutionarily conserved, with animal species also showing distinct markers of an adolescent state [35–40]. Defining the boundaries of adolescence has proved challenging, as there are not clear hallmarks to signal the onset or completion of adolescent development. While puberty and adolescence occur during the same time period, they are not necessarily synonymous: puberty represents the process of attaining sexual maturity, while adolescence is a more diffuse period marked by significant neurobiological, behavioral and social changes. Thus, the age boundaries of the adolescent period are difficult to precisely define. Modern definitions of the human adolescent period range between 10 and 24 years of age [35, 41], an age range where children show dramatic behavioral changes and the human brain undergoes significant restructuring [22, 23, 42, 43]. While there is no clear consensus on the age range of adolescence in animal models, adolescence in rodents is increasingly defined more in line with this larger age window in humans, by counting the period from weaning (~PND 21) where mice and rats gain begin to interact independently with their environments for the first time, leading to a wealth of experiences with the potential to enduringly impact adult behavioral phenotypes and their underlying neuronal circuits. Rodents show behavioral and neurobiological markers of development until neurobiological maturity is reached around two months of age (~PND 60) [36, 38, 39, 44–47]. The adolescent period can be further sub-divided into early (~PND 21–34), middle (~PND 35–45), and late (~PND 45–60) periods [39, 46], which coincide roughly with pre- peri- and post-pubertal periods (Fig. 1). It is important to define these time windows, as striking, age-dependent differences can be reported in the enduring effects of the same experience on neural circuitry depending on the adolescent period in which this experience occurred [48–51]. Thus, we take great care in this review to be as specific as possible about the age at which nicotine exposure occurred during adolescence. Studies in rodent models have begun to elucidate the complex development of neuromodulatory neurotransmitter circuits in adolescence, including those most likely to be directly affected by adolescent nicotine use. Nicotine usurps the action of endogenous acetylcholine (ACh) by signaling through nicotinic acetylcholine receptors (nAChRs), a diverse family of pentameric ligand-gated cation channels [52]. While nAChRs are present throughout the brain at all developmental stages, maturational patterns in their expression and function have been identified [53, 54]. Notably, expression of the most abundant and high-affinity α4β2-containing nAChRs across the brain peaks in adolescence before diminishing to adult levels [55–58], and this peak has been suggested to underlie elevated nicotine self-administration in adolescent animals [59]. This increased nAChR expression was notably observed within the striatum and the midbrain [59]. Studies with greater regional specificity have shown that expression of α4- containing nAChRs in the VTA peaks late in adolescence, and is positively correlated with nicotine intake in an oral self-administration task (Fig. 2A) [60]. Rubidium efflux assays, an index of potassium channel activity, indicate higher nAChR receptor functionality in adolescents than in adults in the cortex, striatum, hippocampus, and thalamus (Fig. 2A) [61, 62]. In parallel to the developmental plasticity of cholinergic receptors, activity of choline acetyltransferase (ChAT), a requisite enzyme for ACh synthesis that also reflects the density of cholinergic innervation, increases from adolescence to adulthood in both the cortex and midbrain (Fig. 2A) [63]. At the cellular level, electrophysiological response to nicotine in cholinergic cells from the laterodorsal tegmentum (LDT), a small brain region located in the brainstem that constitutes the primary source of ACh to the ventral tegmental area (VTA) [64, 65], changes across development, with a larger excitatory response in cells from juvenile mice (PND 7–15) than in late juvenile/early adolescent mice (PND 15–34). This change in nicotine responsivity in LDT neurons is thought to represent a developmental reorganization of the nAChR subunits present on these cells [66, 67]. ACh provides a complex regulation of reward and motivation behaviors through its actions on dopamine (DA) circuitry [68–72]. The release of ACh from LDT projections directly modulates activity of VTA DA neurons, finely tuning their firing rate and burst properties [73, 74]. DA signaling in the striatum is also modulated at the terminal level by ACh release from local striatal cholinergic interneurons [75], but also from an external direct cholinergic input from the LDT [76]. Hence, ACh signaling through presynaptic and somato-dendritic nAChRs tightly regulates DA circuit activity, suggesting that it is another neuromodulatory system profoundly affected by developmental exposure to nicotine. Dopamine circuits undergo a robust period of maturation in adolescence, including changes to innervation patterns, dopamine synthesis and release, basal dopamine neuron firing rates, and dopamine receptor expression in terminal areas, with particularly pronounced changes in mesocortical and mesolimbic circuits (Fig. 2B) [39, 77–82]. Of note, the segregation of mesocorticolimbic dopamine pathways continues in adolescence, with a subset of dopamine axons passing through limbic regions before growing to the PFC [83]. The targeting processes of these axons can be disrupted by experience with stimulant drugs of abuse in adolescence, such as amphetamine [49, 51], or by stress [84], resulting in enduring cognitive deficits. The development of dopaminergic and cholinergic systems may also be inter-related. Adolescent rodents show greater DA release in the NAc in response to acute nicotine when compared to adult counterparts, despite similar baseline measures [85, 86]. Electrophysiological response of VTA DA neurons to acute nicotine also changes across development, with an increased sensitivity in early adolescent animals [87]. Molecular evidence links these changes to maturation in VTA nAChR expression, as mRNA transcripts of α5 α6 and α7 nAChR receptor subunits in the VTA peak early in adolescence (Fig. 2A), in tandem to nicotine-stimulated DA release in the ventral striatum [88]. Together, these results suggest that nicotine in adolescence produces different immediate and long-term outcomes through its actions on these developing neurotransmitter systems.
What the sources say
- Partly supportedcites [55] Doura MB, Gold AB, Keller AB, Perry DC. Adult and periadolescent rats differ in expression of nicotinic cholinergic receptor subtypes and in the response of these subtypes to chronic nicotine exposure. Brain Res. 2008;1215:40–52. sourceExperimental — accuracy not yet measured
The Results (section 2; page unavailable) report higher α4β2⁎ receptor binding in periadolescent than adult rats across 38 sampled brain regions. This supports a widespread adolescent-to-adult difference, but the study compares only those two ages; it does not establish that expression peaks in adolescence, and its finding is limited to rats. (LLM, conf=0.84)
- Not checked — no full text of the sourcecites [56] Trauth JA, Seidler FJ, McCook EC, Slotkin TA. Adolescent nicotine exposure causes persistent upregulation of nicotinic cholinergic receptors in rat brain regions. Brain Res. 1999;851:9–19. source
- Partly supportedcites [57] Counotte DS, Goriounova NA, Moretti M, Smoluch MT, Irth H, Clementi F, et al. Adolescent nicotine exposure transiently increases high‐affinity nicotinic receptors and modulates inhibitory synaptic transmission in rat medial prefrontal cortex. FASEB J. 2012;26:1810–20. sourceExperimental — accuracy not yet measured
The Results (‘3H-epibatidine binding to receptors’; page not supplied) report that α4- and β2-containing receptors decline from early adolescence to adulthood in rat medial prefrontal cortex. The claim extends this pattern across the brain, but the same section finds no age-related decline in occipital cortex; measurements beginning in early adolescence also do not establish a peak at that age. (LLM, conf=0.88)
- Partly supportedcites [58] Cano M, Reynaga DD, Belluzzi JD, Loughlin SE, Leslie F. Chronic exposure to cigarette smoke extract upregulates nicotinic receptor binding in adult and adolescent rats. Neuropharmacology. 2020;181:108308. sourceExperimental — accuracy not yet measured
Results §3.2 (page unavailable) reports higher α4β2 receptor binding in adolescent than adult rats in a majority of the brain regions analyzed. It does not establish that expression peaks in adolescence and then declines, or that the pattern holds across the entire brain; the reported measure is receptor binding, not expression. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Functional imaging studies further indicate that significant changes occur in the function of subcortical structures and in their relationship with cortical regions, notably in nuclei associated with reward and motivation [26–29].”
§ Adolescent nicotine exposure and persistent neurocircuitry changes: unveiling lifelong psychiatric risks > Introduction
What the sources say
- Supportedcites [26] Parr AC, Calabro F, Larsen B, Tervo-Clemmens B, Elliot S, Foran W, et al. Dopamine-related striatal neurophysiology is associated with specialization of frontostriatal reward circuitry through adolescence. Prog Neurobiol. 2021;201:101997. source
The Discussion (page unavailable) reports age-related decreases in functional connectivity between the nucleus accumbens, a subcortical reward region, and several prefrontal cortical regions. It also links developmental changes in nucleus accumbens tissue properties to those connectivity changes, supporting the cited statement about changes in reward circuitry. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [27] Galvan A, Hare TA, Parra CE, Penn J, Voss H, Glover G, et al. Earlier development of the accumbens relative to orbitofrontal cortex might underlie risk-taking behavior in adolescents. J Neurosci. 2006;26:6885–92. source
- Partly supportedcites [28] Larsen B, Luna B. In vivo evidence of neurophysiological maturation of the human adolescent striatum. Dev Cogn Neurosci. 2014;12C:74–85. sourceExperimental — accuracy not yet measured
The Introduction reports fMRI evidence of age-related differences in striatal responses to reward, and the Results (Whole-brain analysis) identify developmental changes in the ventral striatum, a reward-related region. The Discussion (T2* and the adolescent brain) discusses frontostriatal development, but the passages do not establish changes in the functional relationship between subcortical and cortical regions. (LLM, conf=0.82)
- Supportedcites [29] Larsen B, Olafsson V, Calabro F, Laymon C, Tervo-Clemmens B, Campbell E, et al. Maturation of the human striatal dopamine system revealed by PET and quantitative MRI. Nat Commun. 2020;11:846. source
The Discussion reports developmental differences in reward-related striatal activation in human fMRI studies and decreased functional connectivity between the striatum and frontal brain areas during adolescence. It also notes that findings on the direction of striatal reward responses are mixed; the citing sentence does not specify a direction. (LLM, conf=0.90)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
59 more claims · 20 with their cited sources checked
Create a free account to see all 112 claims and every source verdict.
- It may state two separate claims as one. 32
- Probably not a substantial claim. 15
- Borderline: one of the tests for a substantial claim is unclear. 1
Citations
Cites
Dynamic mapping of human cortical development during childhood through early adulthood
Gogtay, N., Giedd, J. N., Lusk, L., Hayashi, K. M., Greenstein, D., Vaituzis, A. C., Nugent, T. F., Herman, D. H., Clasen, L. S., Toga, A. W., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402680101 · Cited by 5,604 · cited 1×
“Indeed, evidence from cross sectional and longitudinal structural MRI studies of human brain development show that gray matter thickness in cortical regions decreases across adolescence before stabilizing at adult levels, while white matter volumes increase [18 – 21].”
Brain development during childhood and adolescence: a longitudinal MRI study
Giedd, J. N., Blumenthal, J., Jeffries, N. O., Castellanos, F. X., Liu, H., Zijdenbos, A., Paus, T., Evans, A. C., & Rapoport, J. L. (1999) · Nature Neuroscience · doi:10.1038/13158 · Cited by 5,552
The adolescent brain and age-related behavioral manifestations
Spear, L. P. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(00)00014-2 · Cited by 5,433 · cited 1×
“Rodents show behavioral and neurobiological markers of development until neurobiological maturity is reached around two months of age (~PND 60) [36, 38, 39, 44 – 47].”
Sawyer, S. M., Azzopardi, P. S., Wickremarathne, D., & Patton, G. C. (2018) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(18)30022-1 · Cited by 3,666
Selected major risk factors and global and regional burden of disease
Ezzati, M., Lopez, A. D., Rodgers, A., Vander Hoorn, S., & Murray, C. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11403-6 · Cited by 3,594
Dopamine, learning and motivation.
Wise, R. A. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1406 · Cited by 3,379 · cited 1×
“…during mid-adolescence (PND 30 – 47), PERSISTENT EFFECTS OF ADOLESCENT NICOTINE EXPOSURE ON DA CIRCUITS DA neurotransmission is essential for diverse behavioral outputs, including motivation, cognition, reward learning, decision making, salience attribution, and voluntary motor control [121 – 127].”
Estimating the true global burden of mental illness
Vigo, D., Thornicroft, G., & Atun, R. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00505-2 · Cited by 2,494
Dopamine in motivational control: rewarding, aversive, and alerting
Bromberg-Martin, E. S., Matsumoto, M., & Hikosaka, O. (2010) · Neuron · doi:10.1016/j.neuron.2010.11.022 · Cited by 2,396
Mapping cortical change across the human life span
Sowell, E. R., Peterson, B. S., Thompson, P. M., Welcome, S. E., Henkenius, A. L., & Toga, A. W. (2003) · Nature Neuroscience · doi:10.1038/nn1008 · Cited by 2,328
Research works printed but not linked: 1
- SAMHSA. Results from the 2011 National Survey on Drug Use and Health: summary of national findings. NSDUH Series H-44, HHS Publication No (SMA) 12-4713. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2012.
Cited by
Sivamaruthi, B. S., Kesika, P., Chaiyasut, C., & Varman, D. R. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1750377 · Cited by 3
“…during neurodevelopment, including adolescent nicotine exposure, induce persistent neurocircuitry alterations that increase life-long psychiatric vulnerability, highlighting critical windows during which microbiome–neurotransmitter interactions may exert amplified effects (Reynolds et al., 2025).”
Ansari, A. A., Akbar, D., Saleh, D. A., Qehs, D. A., Kandari, H. A., Duwailah, R. A., Rashdan, S. A., Mutairi, Y. A., & Ziyab, A. H. (2026) · Tobacco Use Insights · doi:10.1177/1179173x261424137 · Cited by 1
Jeong, C., Kim, B., Oh, D. J., Sohn, T. S., Han, K., & Kwon, H.-S. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112967 · Cited by 2
Chen, M. X., Hing, B. W. Q., Taylor, R. J., & Stevens, H. E. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.06.687006
“Adapted from (8, 11, 29, 30, 127).”
InfluentialFernández-Cáceres, C., Sánchez-Gutiérrez, J. L., & Marín-Navarrete, R. (2025) · Revista Internacional de Investigación en Adicciones · doi:10.28931/riiad.2025.418
Metadata
- Authors
- Reynolds, L. M., Faure, P., & Barik, J.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Reynolds, Lauren M.
- Barik, Jacques
- Venue
- Molecular Psychiatry
- Published
- 2025-08-29
- Volume
- 30
- Issue
- 11
- Pages
- 5534-5545
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- PMC
- PMC12532584
- OpenAlex
- W4413818391
- Cited by
- 26
- References
- 166
- Citations by year
- 2026: 23 · 2025: 3
- FWCI
- 3.37
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Molecular Psychiatry (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Institut National Du Cancer (TABAC-16-022)
- Agence Nationale de la Recherche (ANR-20-CE37-0017, ANR-15-IDEX-01)
- U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Keywords
- adolescent nicotine exposure, acetylcholine system, dopaminergic system, psychiatric risk, substance abuse, anxiety-depressive disorders, schizophrenia, motivational deficits, brain development
- MeSH terms
- Acetylcholine, Adolescent, Animals, Mental Disorders, Brain, Dopamine, Humans, Nicotine, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adolescent nicotine exposure and persistent neurocircuitry changes: unveiling lifelong psychiatric risks. https://app.cochat.ai/papers/10.1038/s41380-025-03110-0
- The paper
- Reynolds, L. M., Faure, P., & Barik, J. (2025). Adolescent nicotine exposure and persistent neurocircuitry changes: unveiling lifelong psychiatric risks. Molecular Psychiatry. https://doi.org/10.1038/s41380-025-03110-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.